Background
==========

The normal function of transforming growth factor β~1~(TGFβ~1~) is essential for the entire organism, representing a multifunctional regulator of cell growth and differentiation \[[@B1]-[@B5]\]. TGFβ~1~is a potent inhibitor of epithelial cell proliferation. Upon binding of TGFβ~1~, TGFβ~1~-receptors phosphorylate SMAD2 or SMAD3 \[[@B6]-[@B12]\]. Phosphorylated SMAD2/3 associates with SMAD4 and, as a complex, moves into the nucleus, where it regulates gene expression \[[@B13]-[@B15]\].

SMAD4 (DPC4) is essential for this TGFβ~1~signaling and transcriptional activation process \[[@B16]\]. In epithelial cells, TGFβ~1~decreases c-myc, cdc2 and cyclin D1 expression, and it increases the expression of c-jun and c-fos \[[@B17]-[@B23]\]. Activation of the TGFβ~1~signal pathway in epithelial cells leads to an increased expression of the cell cycle inhibitors p21^WAF1^and p15^Ink4b^and to a release of formerly sequestered p27^KIP^\[[@B24]-[@B26]\]. It is assumed that the cooperative action of these cell cycle inhibitors results in the growth arrest mentioned above, although p15^Ink4b^does not seem to be necessary in this regard. In addition to mutations in the TGFβ~1~-receptors, in a large number of carcinomas disruptions of this signaling pathway by the alteration of a single protein such as p15^Ink4b^, p16, and p21^Waf1^are found \[[@B2],[@B27]-[@B39]\]. This may result in resistance to the growth-inhibiting action of TGFβ~1~.

In several cell lines, particularly in pancreatic carcinoma cells, resistance to TGFβ~1~could be attributed to a loss of function of the SMAD4 (DPC4) protein \[[@B40]-[@B43]\]. However, the pancreatic carcinoma cell line BxPC-3, although homozygously deleted for SMAD4, is growth inhibited by TGFβ~1~\[[@B30],[@B44]\]. It is thus speculated that alternative signaling pathways in addition to the SMAD pathway may exist.

After binding to α~V~β~6~integrin, latent TGFβ~1~is activated by processing of latent TGFβ~1~by cleavage of the latency-associated Peptide (LAP) \[[@B45]-[@B57]\]. Recently, the interaction of latent TGFβ~1~with α~V~β~6~integrin has been shown \[[@B45]\]. After binding of latent TGFβ~1~to α~V~β~6~integrin, latent TGFβ~1~is activated by cleavage of the latency-associated peptide (LAP) \[[@B45]\]. This α~V~β~6~integrin is also expressed by pancreatic carcinoma cells \[[@B58]-[@B63]\]. We hypothesized that there is a SMAD-independent TGFβ~1~signaling pathway in TGFβ~1~-sensitive carcinoma cells. To address this question, several carcinoma cell lines with different degrees of TGFβ~1~sensitivity were chosen as a model system. We investigated the interaction of TGFβ~1~with the α~V~β~6~integrin and its influence on selected target genes known to be involved in cell cycle-regulated growth inhibition. Here, we demonstrate an alternate TGFβ~1~signaling pathway via α~V~β~6~integrin contributing to TGFβ~1~growth inhibiton in TGFβ~1~sensitive carcinoma cells.

Results
=======

Mature TGFβ~1~induces cytoskeletal immobilization of proteins and tyrosine phosphorylation via integrin α~V~β~6~only in TGFβ~1~sensitive cells
----------------------------------------------------------------------------------------------------------------------------------------------

Only integrins that have bound their ligands are anchored to the cytoskeleton \[[@B64],[@B65]\]. In our experiments, mature TGFβ~1~, α~V~β~6~integrin, and F-actin colocalize (Figure [1](#F1){ref-type="fig"}), suggesting association with and activation of this integrin. To further support this finding, we stimulated cells and performed co-immunoprecipitated various integrin subunits of cytoskeletal anchored proteins \[[@B66],[@B67]\] (additional file [1](#S1){ref-type="supplementary-material"}, [2](#S2){ref-type="supplementary-material"}, [3](#S3){ref-type="supplementary-material"} and [4](#S4){ref-type="supplementary-material"}). Our data strongly suggest that mature TGFβ~1~associates with α~V~β~6~integrin (additional file [1](#S1){ref-type="supplementary-material"}, [2](#S2){ref-type="supplementary-material"}, [3](#S3){ref-type="supplementary-material"} and [4](#S4){ref-type="supplementary-material"}).

![**Colocalization of TGFβ~1~, α~V~β~6~integrin and the cytoskeleton.**Panc-1 cells were stimulated with mature TGFβ~1~and stained using anti TGFβ~1~(labeled with goat anti-rabbit IgG conjugate, A-11046), α~V~/β~6~(labeled with goat anti-rabbit IgG conjugate, A-11046) and Actin antibodies. Magnification 1000×.](1476-4598-2-28-1){#F1}

To determine whether binding of mature TGFβ~1~leads to integrin-mediated signaling, we looked at the status of integrin-cytoskeleton-associated proteins \[[@B66],[@B67]\] after incubation with mature TGFβ~1~in selected carcinoma cell lines with different degrees of sensitivity to TGFβ~1~(Table [1](#T1){ref-type="table"}). Cytoskeletal anchored proteins were precipitated with anti α~V~and β~6~-antibodies. Immobilization of proteins to the cytoskeleton (Triton-X insoluble fraction, Figure [2B](#F2){ref-type="fig"}) as well as tyrosine phosphorylation of these proteins (Figure [2A](#F2){ref-type="fig"}) induced through mature TGFβ~1~was only seen in the TGFβ~1~-sensitive carcinoma cell lines (Figure [2](#F2){ref-type="fig"} and additional file [5](#S5){ref-type="supplementary-material"}). Notably, tyrosine phosphorylation of cytoskeletally anchored proteins is further enhanced after combined treatment with mature TGFβ~1~and fibronectin in TGFβ~1~sensitive cells (Figure [3](#F3){ref-type="fig"}). In contrast, in the TGFβ~1~-resistant AsPC-1 and Capan-1 cells, the interaction of mature TGFβ~1~with α~V~β~6~integrin resulted in an immobilization of high molecular weight proteins to the cytoskeleton without tyrosine phosphorylation (Figure [2](#F2){ref-type="fig"}). Again, stimulation of TGFβ~1~sensitive cells BxPC-3, LoVo \[[@B68]\], SW48 \[[@B68]\], Keratinocytes, HeLa and DLD1 \[[@B69]\], results in an enhanced cytoskeletal immobilization and tyrosine phosphorylation of cellular proteins in response to stimulation with mature TGFβ~1~(additional file [5](#S5){ref-type="supplementary-material"}). Remarkably, preincubation with the MEK1 inhibitor PD98059 resulted in a reduced cytoskeletal immobilization and tyrosine phosphorylation of cellular proteins in response to stimulation with mature TGFβ~1~. This finding is in agreement with other observations that MEK1-mediated signal transduction is involved in cytoskeletal remodeling and integrin engagement \[[@B70],[@B71]\].

###### 

SMAD4 status and TGFβ~1~response of selected tumor cell lines were: (1) confirmed by PCR sequencing (data not shown) and (2) by \[^3^H\] thymidine incorporation assays (data not shown). WT denotes wild type.

  **Cell lines**   **Smad4 status**^1^           **Growth inhibition^2^by TGFβ~1~**
  ---------------- ----------------------------- ------------------------------------
  Panc-1           \+ (WT)                       \+
  BxPC-3           \- (homozygous deleted)       \+
  Capan-1          \- (frame shift mutation)     \-
  AsPC-1           \- (amino acid replacement)   \-
  HeLa             \+ (WT)                       \+
  MCF-7            \+ (WT)                       \+
  MDA-MB-231       \+ (WT)                       \+

![**Phosphorylation and immobilization of proteins associated with the integrin-cytoskeleton-complex.**Cytoskeletally anchored α~V~β~6~was immunoprecipitated after TGFβ~1~stimulation (10 nM for 10 minutes) followed by Western analysis with antibodies against tyrosine-phosphorylated proteins (A) or Western blotting after biotinylation of all proteins and streptavidin detection (B). Presence of TGFβ~1~(C), α~V~and β~6~integrin (D) in the co-precipitates is also demonstrated. TGFβ-receptor-I and II (TGFβRI and TGFβRII) are expressed at nearly equal levels in all cell lines as demonstrated by western blotting from whole cell extracts (E). In part the cells were preincubated with α~V~- and β~6~-antibodies (1:100 each for 30 min) or with a TGFβ antibody (15 μg/ml for 30 min).](1476-4598-2-28-2){#F2}

![**Enhanced Tyrosine Phosphorylation of proteins associated with the integrin-cytoskeleton-complex.**Cytoskeletally anchored α~V~β~6~was immunoprecipitated after TGFβ~1~and/or fibronectin stimulation (10 nM for 10 minutes) followed by Western analysis with antibodies against tyrosine-phosphorylated proteins (A). Reprobing with α~V~and β~6~antibodies show equal anounts of precipitates used (B).](1476-4598-2-28-3){#F3}

Activation of p125^FAK^, a central step in integrin-associated signaling \[[@B72],[@B73]\], was determined to assess integrin-mediated signaling. BcPC-3 cells are sensitive to TGFβ~1~but are SMAD4 deleted. We incubated BxPC-3 cells with mature TGFβ~1~and observed an association on the cytoskeleton connected with integrin α~V~β~6~and activation of p125^FAK^(Figure [4](#F4){ref-type="fig"}). Indeed, TGFβ~1~antibodies, cytochalasin D and BAPTA-AM \[[@B66]\] abolished the association on the cytoskeleton connected with integrin α~V~β~6~and activation of p125^FAK^. These data further suggest that TGFβ~1~mediated activation of p125^FAK^depends on free intracellular calcium and an intact actin cytoskeleton.

In order to test whether TGFβ~1~signaling via α~V~β~6~is specific for SMAD4 deleted BxPC-3 cells or if this is a general phenomenon, we investigated signaling in TGFβ~1~-sensitive carcinoma cell lines HeLa, MCF-7 and MDA-MB-231. TGFβ~1~induced recruitment of p125^Fak^, p130^Cas^and Sos1/2 to the cytoskeleton. Enhanced expression of c-jun, c-fos, p21^WAF1^and p27^KIP^, while downregulating PCNA, is dependent on ERK1/2 signaling, an intact cytoskeleton and intracellular calcium (Figures [5](#F5){ref-type="fig"}, [6A](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"}, [8](#F8){ref-type="fig"} and additional files [6](#S6){ref-type="supplementary-material"}, [7](#S7){ref-type="supplementary-material"} and [8](#S8){ref-type="supplementary-material"}). We also confirmed the purity of the commercially available mature TGFβ~1~used in these experiments by silver stained non-reducing SDS-PAGE, with latent TGFβ~1~as control (Figure [6B](#F6){ref-type="fig"}). We also demonstrated the SMAD4 deficiency of the BxPC-3 cells used (Figure [6C](#F6){ref-type="fig"}).

![**p125^FAK^activation by mature TGFβ~1~via integrin α~V~β~6~**. Stimulation of BxPC-3 with mature TGFβ~1~(10 nM for 10 minutes), immunoprecipitation with α~V~- and β~6~integrin antibodies after preparation of the cytoskeleton, followed by probing with pp125^Fak^and p125^FAK^antibodies. In part the cells were preincubated with α~V~- and β~6~-antibodies (1:100 each for 30 min), with a TGFβ antibody (15 μg/ml for 30 min), cytochalasin D and BAPTA AM, respectively.](1476-4598-2-28-4){#F4}

![**Cell cycle genes in response to TGFβ~1~.**Western Blot analysis of HeLa cells stimulated with 10 nM of mature TGFβ~1~for the time indicated. Cytoskeletally anchored proteins are differentially marked. In part the cells were preincubated with α~V~- and β~6~-antibodies (1:100 each for 30 min), with a TGFβ-RII antibody (15 μg/ml for 30 min), cytochalasin D, BAPTA AM and MEK1 inhibitor PD98059, respectively.](1476-4598-2-28-5){#F5}

![**Enhanced level of cytoskeletal anchored proteins in response to TGFβ~1~(A).**Western Blot analysis of BxPC-3 and HeLa cells as indicated after stimulation with TGFβ~1~for the time indicated. Cytoskeletally anchored proteins are differentially marked. In part the cells were preincubated with α~V~- and β~6~-antibodies (1:100 each for 30 min), with a TGFβ-RII antibody (15 μg/ml for 30 min), cytochalasin D, BAPTA AM and MEK1 inhibitor PD98059, respectively. **Purity of the TGFβ~1~used (B).**Ten nanogram of mature TGFβ~1~and latent TGFβ~1~were subjected to non-reducing SDS-PAGE dollowed by silver staining. No latant TGFβ~1~could be detected in the mature TGFβ~1~used for stimulation. **BxPC-3 cells are *SMAD4***^-/-^**(C).**One hundred microgram of whole cell extract from BxPC-3 and HeLa cells were probed with p125^FAK^and SMAD4 antibodies on the same membrane. As reported, BxPC-3 cells are found to be *SMAD4*^-/-^.](1476-4598-2-28-6){#F6}

![**Cell cycle genes in response to TGFβ~1~.**Western Blot analysis of MCF-7 and MDA-MB 231 cells as indicated after stimulation with TGFβ~1~for the time indicated. Cytoskeletally anchored proteins are differentially marked. In part the cells were preincubated with α~V~- and β~6~-antibodies (1:100 each for 30 min), with a TGFβ-RII antibody (15 μg/ml for 30 min), cytochalasin D, BAPTA AM and MEK1 inhibitor PD98059, respectively.](1476-4598-2-28-7){#F7}

![**Cell cycle genes in response to TGFβ~1~.**Western Blot analysis of BxPC-3, LOVO, SW48 and DLD1 cells as indicated after stimulation with TGFβ~1~for the time indicated. Cytoskeletally anchored proteins are differentially marked. In part the cells were preincubated with α~V~- and β~6~-antibodies (1:100 each for 30 min), with a TGFβ-RII antibody (15 μg/ml for 30 min), cytochalasin D, BAPTA AM and MEK1 inhibitor PD98059, respectively.](1476-4598-2-28-8){#F8}

TGFβ~1~/α~V~β~6~integrin signaling is independent of the known TGFβ~1~signaling pathway
---------------------------------------------------------------------------------------

To explain the TGFβ~1~sensitivity of SMAD4-deleted cells, it is speculated that after binding of TGFβ~1~to its receptor, activated SMAD2/3 may translocate to the nucleus and activate gene expression even in the absence of SMAD4. To exclude this possibility, cellular proteins were divided into cytoplasmatic and nuclear fractions after TGFβ~1~stimulation, and localization and phosphorylation of SMAD2/3 were investigated. In the SMAD4 deleted BxPC-3 cells, TGFβ~1~resulted in phosphorylation of SMAD2/3, but the activated SMAD proteins were retained in the cytoplasmatic fraction (Figure [9](#F9){ref-type="fig"}). Remarkably, in NP-9 cells \[[@B74]\], SMAD2/3 are translocated into the nucleus upon TGFβ~1~stimulation (additional file [9(A)](#S9){ref-type="supplementary-material"}) but we could not observe an enhanced tyrosine phosphorylation of cytoskeletal anchored proteins (additional file [9(B)](#S9){ref-type="supplementary-material"}).

![**Activation and nuclear translocation of SMAD2/3 in response to TGFβ~1~(A).**Nuclear and cytoplasmatic fraction of cellular proteins (BxPC-3) after stimulation with 10 nM of TGFβ~1~for 10 minutes and Western blot analysis for SMAD2/3 and phosphorylated SMAD2/3. **Purity of cytoplasmic and nuclear fraction (B).**Cytoplasmic and nuclear extracts from K562 cells were probed with p125^FAK^, PCNA and Iκ Bα antibodies at the same time. As predicted, p125^FAK^cold exclusively be detected in the cytoplasmic extract, whereas PCNA is found in the nucleus. Iκ Bα served as loading control.](1476-4598-2-28-9){#F9}

TGFβ~1~mediated growth inhibition is dependent on α~V~β~6~integrin
------------------------------------------------------------------

Influence of TGFβ~1~on cell growth is well established, but the mechanisms are not fully understood \[[@B75]-[@B79]\]. Here, we assayed for the possible synergistic function of α~V~β~6~integrin on mature TGFβ~1~mediated growth inhibition in Panc-1 cells. As shown in the additional file [10](#S10){ref-type="supplementary-material"}, combined treatment with α~V~and β~6~blocking antibodies almost completely abolished the effect of mature TGFβ~1~on the growth of Panc-1 cells. We therefore postulate that the growth inhibition of TGFβ~1~is synergistically influenced by α~V~β~6~integrin.

Discussion
==========

A recent study demonstrated an interaction of latent TGFβ~1~with α~V~β~6~integrin, which led to an activation of latent TGFβ~1~\[[@B45]\]. Incubation of different tumor cells with mature TGFβ~1~resulted in a direct binding of TGFβ~1~to α~V~β~6~integrin. Certain integrins appear to be preferentially associated with specific growth factor receptors \[[@B80]\]. The interaction of these two receptor classes seems to take place via the actin cytoskeleton. We were able to exclude such signal pathway association, since in our cytoskeletal preparations, no TGFβ~1~-receptors were detectable, indicating that mature TGFβ~1~is a ligand for α~V~β~6~.

It has been reported that activated integrins are associated with the cytoskeleton. Here, we show that binding of mature TGFβ~1~to α~V~β~6~integrin resulted in an association of the cytoskeleton (Figure [10](#F10){ref-type="fig"}). In a variety of integrin-mediated signaling pathways, tyrosinephosphorylation of proteins immobilized to the cytoskeleton is enhanced \[[@B66],[@B67]\]. The same was true in our experimental settings only for the TGFβ~1~-sensitive cells. This upregulation of tyrosine phosphorylation was inhibited by preincubation with a TGFβ~1~neutralizing antibody or by blocking of α~V~β~6~integrin, thus again proving mature TGFβ~1~as an initial signaling ligand for α~V~β~6~.

![**Hypothesis about an alternate TGFβ~1~signaling pathway via α~V~β~6~integrin, independent of RGD.**This pathway may be required for full TGFβ~1~induced transcriptional activation, which explains the TGFβ~1~sensitivity of those cells lacking DPC4/SMAD4 function that still react with growth inhibition.](1476-4598-2-28-10){#F10}

Binding of mature TGFβ~1~to α~V~β~6~integrin exerts several downstream effects in TGFβ~1~-sensitive cells (Figure [9](#F9){ref-type="fig"}). One is a marked phosphorylation of p125^FAK^. This phosphorylation is dependent on the integrity of the cytoskeleton, as disruption of actin filaments by cytochalasin D completely eliminated this effect, findings which have also been reported for several integrin signaling pathways \[[@B66],[@B67]\]. Moreover, incubation of the TGFβ~1~sensitive carcinoma cells with TGFβ~1~caused immobilization of the docking protein p130^cas^and of the guanine nucleotide exchange factor SOS to the cytoskeleton. Beyond this, a marked induction of the cell cycle inhibitors p21^WAF1^and p27^KIP^and a decrease in PCNA expression was detectable.

Finally, TGFβ~1~caused an activation of p21Ras and the MAP kinases ERK1 and ERK2. This TGFβ~1~-induced expression profile was not affected by preincubation of SMAD4 deleted BxPC-3 cells with a TGFβ~1~-RII blocking antibody, which was able to completely block TGFβ~1~-induced SMAD2/3 phosphorylation, thus demonstrating the independence of the TGFβ~1~-signaling from the known SMAD pathway in BxPC-3 cells. In contrast, preincubation with α~V~- and β~6~-blocking antibodies curbed the TGFβ~1~-induced regulation of p21/WAF1, p27, c-fos, and the p21Ras and ERK1/2 activation, verifying that the binding of TGFβ~1~to the α~V~β~6~integrin is a prerequisite for the activation of the signal pathway via the α~V~β~6~integrin. Preincubation of the cells with the MEK1 inhibitor PD98059 curbed the TGFβ~1~-induced regulation of these genes as well, indicating the involvement of the MAP kinase pathway in TGFβ~1~signaling in BxPC-3 cells. As shown recently, the growth-stimulatory effect of the TGFβ superfamily member BMP-2on CAPAN-1 cells was blocked by this inhibitor as well \[[@B81]-[@B83]\], supporting our findings.

Indeed, cytoskeletal immobilization of p130cas and SOS was not prevented by the MEK1 inhibitor PD 98059. Thus, these proteins are good candidates to link the integrin-mediated TGFβ~1~signaling to the MAP kinase pathway, as was shown previously for signaling events induced by fluid stress or integrin mediated cell-adhesion in other cell types \[[@B71],[@B84]-[@B91]\].

In order to generalize the integrin mediated TGFβ~1~-pathway identified in the SMAD4 deleted pancreatic tumor cell line BxPC-3, we investigated TGFβ~1~signaling in the cervical carcinoma cell line HeLa and the mammary carcinoma cell lines MCF-7 and MDA-MB-231, harboring a wildtype SMAD4-gene. TGFβ~1~bound to α~V~β~6~-integrin in these cells as well, and this interaction resulted both in an immobilization of p130Cas and SOS1/2 and in tyrosine phosphorylation of cytoskeleton-associated proteins such as p125FAK. TGFβ~1~stimulation of these cells acvtivated p21Ras and MAPK ERK1/2, upregulated c-fos, c-jun/AP1, p21/WAF1 and p27 expression, and resulted a decrease of PCNA, similar to its actions in BxPC-3 cells. Preincubation with a TGFβ-RII blocking antibody attenuated the TGFβ~1~induced pattern, contrary to SMAD 4 deleted BxPC-3 cells. This preincubation also decreased activation of p21Ras and of MAPK ERK1/2, indicating the participation of the Ras/MAPK-pathway in TGFβ~1~induced transcriptional activation.

The same attenuation of TGFβ~1~induced gene expression and the decrease in p21Ras and MAPK ERK1/2 activation was observable after preincubation of SMAD4 wildtype cells with α~V~β~6~-blocking antibodies, demonstrating that TGFβ~1~signaling via α~V~β~6~-integrin also is linked to the Ras/MAPK-pathway, and that both pathways have synergistic effects in TGFβ~1~-signaling. Full TGFβ~1~induced transcriptional activation is only reached if both pathways are completed. This finding is supported by the observation that activation of p21/Ras and MAPK ERK1/2 induced by TGFβ~1~is only reverted to the control level by the combination of the TGFβ-RII blocking antibody and the α~V~β~6~-blocking antibodies, or by inhibition of MEK1.

Linking of the TGFβ-R pathway to the Ras/MAPK pathway is dependent on a functional SMAD4 gene product, because TGFβ~1~induced gene expression and activation of Ras and ERK1/2 is attenuated by the TGFβ-RII blocking antibody only in SMAD4 wild type cells, whereas in the SMAD4 deleted BxPC-3 cells, no such influence was observable.

Based on our results, we suggest the following model of TGFβ~1~-signaling, which offers an explanation for the different growth responses to TGFβ~1~(Fig. [10](#F10){ref-type="fig"}). In the TGFβ~1~-sensitive cell lines with intact SMAD pathway, the TGFβ~1~response can be attributed to both the common SMAD signaling pathway and the integrin pathway described above. In the cell line BxPC-3, lacking the SMAD4 gene product, the SMAD4-independent pathway can explain the TGFβ~1~sensitivity via α~V~β~6~integrin, the cytoskeleton and the Ras/MAP kinase pathway, resulting in an upregulation of the cell cycle inhibitiors p21/WAF1 and p27, which in turn results in the TGFβ~1~-induced growth inhibition (additional file [10](#S10){ref-type="supplementary-material"}).

The cell lines Capan-1 and AsPC-1 are not only resistant to TGFβ~1~because of their alterations in the SMAD pathway, but also because they cannot complete the alternate pathway, as demonstrated above. Furthermore, this alternate pathway may explain the TGFβ~1~resistance of cells with no detectable defect in the SMAD pathway \[[@B92]-[@B101]\], as one can imagine that the cooperative action of the both pathways is necessary to exert the complete growth inhibitory effect of TGFβ~1~. Comparable effects have been described for the synergistic operation of growth factor receptor and anchorage dependent integrin signaling \[[@B102]-[@B119]\].

Recombinant mature TGFβ~1~does not contain a RGD motif, and thus binding of TGFβ~1~to the α~V~β~6~integrin and the subsequent activation of this integrin must rely on a novel motif distinct from RGD. For α~V~β~6~integrin, a novel non-RGD ligand recognition motif was recently described with the consensus motif DLXXL \[[@B120]\].

This motif has been detected on several proteins, including laminin, collagen and fibrinogen \[[@B120]\]. A BLAST search for this sequence in TGFβ~1~revealed a 70% similar motif in two parts of the molecule; one in the LAP (data not shown) and one in the mature TGFβ~1~. In mature TGFβ~1~, the DLXXL motif is freely accessible for interactions on the outside of the molecule. Therefore, it may be speculated that TGFβ~1~binding to α~V~β~6~via this novel ligand recognition motif is facilitating the signaling. Moreover, a non-RGD ligand binding pocket in addition to the usual RGD binding site has been demonstrated for fibrinogen and the α~IIb~β~3~integrin \[[@B121]\], supporting our findings.

Conclusions
===========

We demonstrate an alternate TGFβ~1~signaling pathway via α~V~β~6~integrin, independent of SMAD4. This pathway seems to be required for full TGFβ~1~induced transcriptional activation, which explains the TGFβ~1~sensitivity of those cells lacking DPC4/SMAD4 function that still react with growth inhibition.

Methods
=======

Cell Culture and TGFβ~1~stimulation
-----------------------------------

All cells were obtained from from ATCC and maintained in DMEM supplemented with 17% fetal calf serum. Recombinant human proteins (mature TGFβ~1~, TNF-α, Fibronectin and Laminin 1) were purchased from R&D Systems. 10^6^cells were grown overnight in 6 cm diameter dishes with DMEM/10 % FCS. After washing twice with PBS (pH 7.4), fresh DMEM without FCS was added to the monolayer. Cells were stimulated with 10 nM of mature TGFβ~1~or with fibronectin as described below. In blocking experiments, cells were preincubated with either a TGFβ~1~-RII-blocking antibody (R&D Systems \# AF-241-NA, 15 μg/ml for 30 min), α~V~and β~6~-blocking antibodies (Santa Cruz, sc-6617 and sc-6632 respectively, 1:100 each for 30 min), or the MEK1 inhibitor PD98059 (New England Biolabs \# 9900S, 7.5 ng/ml for 10 min) before stimulation with mature TGFβ~1~.

Indirect immunofluorescence
---------------------------

For indirect immunofluorescence, 10^4^cells were cultured on glass coverslips, stimulated with 10 nM mature TGFβ~1~for 10 minutes, stained as described \[[@B66],[@B67]\] and viewed using a Zeiss LSM-510 confocal microscope. Antibodies used were: actin (sc-8432), TGFβ~1~(sc-146), α~V~(sc-6617) and β~6~(sc-6632). The following fluorochrome-labeled antibodies were used (AlexaFluor, Molecular Probes): goat anti-mouse IgG (H+L) conjugate (\#A-11032; red), goat anti-rabbit IgG (H+L) conjugate (\#A-11046; blue), and donkey anti-goat IgG (H+L) conjugate (\#A-11055; green).

Preparation of cytoplasmatic proteins and of nuclei
---------------------------------------------------

Cellular fractionation was performed as described in earlier reports \[[@B122]-[@B125]\]. Cells were scraped into 100 μl of ice-cold buffer A \[10 mM Hepes (pH 7.9); 1.5 mM MgCl~2~; 10 mM KCl; 0.5 mM DTT; 0.05% NP-40\]. Nuclei were pelleted in a microcentrifuge for 10 sec. at 4°C and 15,000 G. The supernatant was used to analyze cytoplasmatic proteins, nuclei were resuspended in 60 μl of ice cold buffer B \[20 mM Hepes (pH 7.9); 25% (v/v) glycerol; 420 mM KCl; 1.5 mM MgCl~2~; 0.2 mM EDTA; 0.5 mM DTT; 0.5 mM PMSF\] and incubated on ice for 15 min.

Preparation of actin filaments of the cytoskeleton and immunoprecipitation
--------------------------------------------------------------------------

The cell monolayer was incubated with cell extraction buffer \[0.1 % Triton X-100, 80 mM KCl, 20 mM imidazole, 2 mM MgCl~2~, 2 mM EGTA, pH 7.8\] for 5 min at 4°C. The Triton-insoluble fractions were then scraped into cold Triton X-100 lysis buffer \[50 mM Tris/HCl (pH 7.4); 100 mM NaCl; 50 mM NaF; 5 mM EDTA; 40 mM glycerophosphate; 1 mM sodium orthovanadate; 100 μM PMSF; 1 μM leupeptin; 1 μM pepstatin A; 1% (v/v) Triton X-100\] and incubated for 20 min on ice, and clarified by centrifugation at 13000 g for 5 min at 4°C. For immunoprecipitation, the lysates were incubated for 4 h at 4°C with 1 μg of antibody (all from Santa Cruz) pre-adsorbed on Protein A-Sepharose beads (Pharmacia). Immune complexes were washed five times with cold Triton X-100 lysis buffer. For re-precipitation, the pellet was boiled in 10 μl 0.1% SDS for 5 min and diluted 1:20 in the Triton X lysis buffer followed by the precipitation procedure. All samples were boiled in Laemmli denaturing buffer and analyzed by Western blotting. Whole cell lysates serving as positive controls were prepared by incubating monolayers with denaturing Laemmli buffer.

Treatment with Cytochalasin and Calcium Chelator
------------------------------------------------

To disrupt the actin filaments of the cytoskeleton, the cell monolayer was treated with 25 nM cytochalasin D for 20 min at 37°C; TGFβ~1~was then applied in the presence of 25 nM cytochalasin D. For chelating intracellular calcium, the cells were preincubated with 5 μM of 1,2-bis(2-aminophenoxy)ethane-*N*,*N*,*N*\',*N*\'-tetraacetic acid, acetoxymethyl ester (BAPTA-AM) for 15 min. TGFβ~1~was then applied in the presence of 5 μM of BAPTA.

\[^3^H\]-thymidine incorporation assay
--------------------------------------

For the TGFβeta~1~growth inhibition assay, cells were seeded in 96-well microtitier plates at 10^4^cells/well in 100 μl of culture medium containing 10% FCS. After 24 h, medium was replaced by culture medium supplemented with 0.5% FCS. After an additional 24 h, cells were treated with 10 nM of mature TGFβ~1~. After incubation with TGFβ~1~for 21 h, cells were pulsed with 200 nCi of \[^3^H\]-thymidine (1.74 TBq/mmol; Amersham, UK) for 3 h without changing the medium. Cells were washed once with PBS, incubated with trypsin for 10 min and collected by using a Skatron cell harvester. Radioactivity incorporated was determined by liquid scintillation counting.

Western Blot
------------

Proteins were separated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Roche) as described previously \[[@B66]\]. Blot membranes were blocked for 3 h at 37°C in PBS containing 5 % skim milk and probed with the respective antibodies (16 h at 4°C). The following antibodies were used in a dilution of 1:1,000: TGFβ~1~(Santa Cruz \[sc\], sc-146), p-Tyr (sc-7020), β~6~-integrin (sc-6632), α~V~-integrin (sc-6617), p125^FAK^(sc-557), TGFβ~1~-RI (sc-402), TGFβ~1~-RII (sc-400-G), ERK1/2-P (sc-7383), SMAD2/3 (sc-6033), SOS1/2 (sc-259), p130^cas^(UBI-06-500), PCNA (sc-56), p21^WAF1^(sc-6246), p27^KIP^(sc-1641), c-fos (sc-7202), c-jun (sc-44), raf1 (sc-133), p21^Ras^(sc-35) and phospho-threonine antibody (New England Biolabs, \# 9381). Detection antibodies (all from Dako; 1:5,000 for 1 h at room temperature) were mouse-anti-goat Ig, mouse-anti-rat Ig, rabbit-anti-mouse Ig, and porcine-anti-rabbit Ig-HRP \[[@B66]\]. To visualize all transferred proteins, we used the ECL protein biotinylation labeling modules (RPN 2202, Amersham) and streptavidin alkaline phosphatase (V020402, Amersham) in accordance with the manufacturer\'s instructions.

Ras activation assay
--------------------

Only activated p21^Ras^is able to bind Raf1, leading to a Raf1-translocation to the cell membrane. After stimulation with 10 nM mature TGFβ~1~for 10 minutes, cells were incubated in sterile water until they lysed. The membrane fraction was lysed in Triton X-100 lysis buffer. Precipitation against Raf1 and analysis for p21^Ras^followed.
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###### Additional File 1

Portable Network Graphic (PNG) File showing that mature TGFβ~1~binds to α~V~β~6~integrin. The cells indicated were stimulated for ten minutes with 10 nM of either mature TGFβ~1~, tumor necrosis factor α (TNFα) or fibronectin (FN). Cytoskeletal anchored proteins were extracted, co-immunoprecipitated (IP) and analyzed (Blot) with the antibodies indicated.

###### 

Click here for file

###### Additional File 2

Portable Network Graphic (PNG) File showing that mature TGFβ~1~binds to α~V~β~6~integrin. The cells indicated were stimulated for ten minutes with 10 nM of either mature TGFβ~1~, tumor necrosis factor α (TNFα), laminin-1 (Lam1) or fibronectin (FN). Cytoskeletal anchored proteins were extracted, co-immunoprecipitated (IP) and analyzed (Blot) with the antibodies indicated.

###### 

Click here for file

###### Additional File 3

Portable Network Graphic (PNG) File showing that mature TGFβ~1~binds to α~V~β~6~integrin and the speciticity of the signals detected as well. The cells indicated were stimulated for ten minutes with 10 nM of either mature TGFβ~1~, tumor necrosis factor α (TNFα), or fibronectin (FN). Cytoskeletal anchored proteins were extracted, co-immunoprecipitated (IP) and analyzed (Blot) with the antibodies indicated.

###### 

Click here for file

###### Additional File 4

Portable Network Graphic (PNG) File showing the speciticity of the signals detected. The cells indicated were stimulated for ten minutes with 10 nM of either mature TGFβ~1~, tumor necrosis factor α (TNFα), or fibronectin (FN). Cytoskeletal anchored proteins were extracted, and analyzed (Blot) with secondary antibodies (α-mouse HRP plus α-rabbit HRP plus α-goat HRP conjugated antibodies.)

###### 

Click here for file

###### Additional File 5

Portable Network Graphic (PNG) File showing enhanced cytoskeletal immobilization and tyrosine phosphorylation of cellular proteins in response to stimulation with mature TGFβ~1~. Cytoskeletally anchored α~V~β~6~was immunoprecipitated after TGFβ~1~stimulation (10 nM for 10 minutes) followed by Western analysis with antibodies against tyrosine-phosphorylated proteins (A) or Western blotting after biotinylation of all proteins and streptavidin detection (B). In part the cells were preincubated with α~V~- and β~6~-antibodies (1:100 each for 30 min) or with a TGFβ-RII antibody (15 μg/ml for 30 min).

###### 

Click here for file

###### Additional File 6

Portable Network Graphic (PNG) File showing cell cycle genes in response to TGFβ~1~. Western Blot analysis of HeLa, MCF-7 and Keratinocytes (Keratino) cells as indicated after stimulation with TGFβ~1~for the time indicated. Cytoskeletally anchored proteins are differentially marked. In part the cells were preincubated with α~V~- and β~6~-antibodies (1:100 each for 30 min), with a TGFβ-RII antibody (15 μg/ml for 30 min), cytochalasin D, BAPTA AM and MEK1 inhibitor PD98059, respectively.

###### 

Click here for file

###### Additional File 7

Portable Network Graphic (PNG) File showing that PCNA regulation is dependent on α~V~β~6~integrins, intact cytoskeleton and free intracellular calcium. BxPC-3 cells were stimulated with 10 nM of mature TGFβ~1~for 6 hours. In part the cells were preincubated with α~V~- and β~6~-antibodies (1:100 each for 30 min), with a TGFβ antibody (15 μg/ml for 30 min), cytochalasin D and BAPTA AM, respectively. Whole cell extract was probed with PCNA antibodies. Actin served as loading control.

###### 

Click here for file

###### Additional File 8

Portable Network Graphic (PNG) File showing tha regulation of p27, p21, c-fos and c-jun are dependent on α~V~β~6~integrins, intact cytoskeleton and free intracellular calcium. BxPC-3 cells were stimulated with 10 nM of mature TGFβ~1~for 6 hours. In part the cells were preincubated with α~V~- and β~6~-antibodies (1:100 each for 30 min), with a TGFβ-RII antibody (15 μg/ml for 30 min), cytochalasin D and BAPTA AM, respectively. Whole cell extract was probed with PCNA antibodies. Actin served as loading control.

###### 

Click here for file

###### Additional File 9

Portable Network Graphic (PNG) File showing activation and nuclear translocation of SMAD2/3 in response to TGFβ~1~(A). Nuclear and cytoplasmatic fraction of cellular proteins (NP9) after stimulation with 10 nM of TGFβ~1~for 10 minutes and Western blot analysis for SMAD2/3 and phosphorylated SMAD2/3. Cytoskeletally anchored α~V~β~6~was immunoprecipitated after TGFβ~1~stimulation (10 nM for 10 minutes) followed by Western analysis with antibodies against tyrosine-phosphorylated proteins (C) or Western blotting after biotinylation of all proteins and streptavidin detection (D). In part the cells were preincubated with α~V~- and β~6~-antibodies (1:100 each for 30 min) or with a TGFβ antibody (15 μg/ml for 30 min).

###### 

Click here for file

###### Additional File 10

Microsoft Excel spreadsheet showing TGFβ~1~elicited growth inhibition of Panc-1 cells is dependent on α~V~β~6~integrin function. The assay was performed as described in the \"Methods\" section.

###### 

Click here for file
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